These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12971396)

  • 21. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 22. Genentech awarded critical antibody patent.
    Robertson D
    Nat Biotechnol; 2002 Feb; 20(2):108. PubMed ID: 11821843
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent patent applications in antibodies.
    Nat Biotechnol; 2007 Jan; 25(1):58. PubMed ID: 17211397
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent patent applications related to antibacterials.
    Nat Biotechnol; 2006 Dec; 24(12):1532. PubMed ID: 17160058
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent patent applications in DNA synthesis.
    Nat Biotechnol; 2007 Jun; 25(6):642. PubMed ID: 17557097
    [No Abstract]   [Full Text] [Related]  

  • 26. Patent protection for protein structure analysis.
    Shimbo I; Nakajima R; Yokoyama S; Sumikura K
    Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent patent applications in microRNAs.
    Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent patent applications relating to peptide therapeutics.
    Nat Biotechnol; 2006 Jun; 24(6):656. PubMed ID: 16763592
    [No Abstract]   [Full Text] [Related]  

  • 29. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent patent applications in angiogenesis research.
    Nat Biotechnol; 2006 Feb; 24(2):155. PubMed ID: 16465155
    [No Abstract]   [Full Text] [Related]  

  • 31. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 33. [European patent].
    Saviotti G
    Farmaco Prat; 1974 Jan; 29(1):18-20. PubMed ID: 4455518
    [No Abstract]   [Full Text] [Related]  

  • 34. [The status of a nonpatented drug of which the basic molecule in patented].
    Petranker L; Stenger J
    Ann Pharm Fr; 1975 Nov; 33(11):619-25. PubMed ID: 1231608
    [No Abstract]   [Full Text] [Related]  

  • 35. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of drug patent abolition on a Canadian pharmaceutical company.
    LOZINSKI E
    Appl Ther; 1963 May; 5():441-2. PubMed ID: 13931335
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug research. WHO panel weighs radical ideas.
    Enserink M
    Science; 2006 Dec; 314(5804):1373. PubMed ID: 17138875
    [No Abstract]   [Full Text] [Related]  

  • 38. Are drug proprietary names necessary?
    D'Arcy PF; Hadden DR
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of drug patent abolition on an international pharmaceutical company.
    DAILY RF
    Appl Ther; 1963 May; 5():445-7. PubMed ID: 14024668
    [No Abstract]   [Full Text] [Related]  

  • 40. More lawyers. More bureaucrats. Less information on drug safety.
    Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):394-5. PubMed ID: 16739244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.